Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 2, 2014, Pages 124-128

  Chang, Tiffany R ^a,b   Albright, Karen C ^c,d,e,f   Boehme, Amelia K ^c,f   Dorsey, Adrianne ^a   Sartor, E Alton ^a   Kruse Jarres, Rebecca ^a   Leissinger, Cindy ^a   Martin Schild, Sheryl ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Center for Outcomes and Effectiveness Research   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

atherosclerosis; blood coagulation factors; clinical epidemiology; hypercoagulability; stroke; vascular disease

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RANKIN SCALE; VERY ELDERLY; YOUNG ADULT;

ATHEROSCLEROSIS; BLOOD COAGULATION FACTORS; CLINICAL EPIDEMIOLOGY; HYPERCOAGULABILITY; STROKE; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOPHILIA;

EID: 84893507820     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613488936     Document Type: Article

References (21)

1. Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol. 2001 ; 21 (5). 731-738
2. Shahsavarzadeh T, Javanmard SH, Saadatnia M. Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: are they independent risk factors?. Eur Neurol. 2011 ; 66 (4). 243-246
3. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995 ; 345 (8943). 152-155
4. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000 ; 343 (7). 457-462
5. Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The atherosclerosis risk in communities (ARIC) study. Thromb Haemost. 1993 ; 70 (3). 380-385
6. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987 ; 69 (6). 1691-1695
7. Jeremic M, Weisert O, Gedde-Dahl TW., Factor VIII. (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest. 1976 ; 36 (5). 461-466
8. Qi L, Rimm E, Manson J, Hu F, Rexrode K 2011 :
9. Amberger N, Weih M, Harms L, Valdueza JM. Third occurrence of cerebral venous thrombosis in a 33-year-old woman. Cerebrovasc Dis. 2006 ; 21 (5-6). 416-418
10. Ayo-Martin O, Garcia-Garcia J, Sopelana D, Segura T. Traveler's stroke: it is not just flying that does it. Cerebrovasc Dis. 2008 ; 26 (5). 566-568
11. Tichelaar V, Mulder A, Kluin-Nelemans H, Meijer K. The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis. Thromb Res. 2012 ; 129 (2). 183-186
12. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol. 2001 ; 115 (1). 3-12
13. O'Donnell J, Mumford AD, Manning RA, Laffan M.. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost. 2000 ; 83 (1). 10-13
14. Kamphuisen PW, Eikenboom JC, Vos HL, et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost. 1999 ; 81 (5). 680-683
15. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Circulation. 1997 ; 96 (4). 1102-1108
16. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The atherosclerosis risk in communities (ARIC) study Investigators. Circulation. 1999 ; 100 (7). 736-742
17. Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the caerphilly heart study. Br J Haematol. 1999 ; 105 (1). 110-116
18. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ., Factor VIII. ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994 ; 88 (3). 601-607
19. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, Martin-Schild S. What change in the national institutes of health stroke scale should define [published online June 21, 2012]. J Stroke Cerebrovasc Dis. 2012 ;:
20. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993 ; 24 (1). 35-41
21. Bender R, Lange S. Adjusting for multiple testing - when and how?. J Clin Epidemiol. 2001 ; 54 (4). 343-349